Sterneck Capital Management’s Biocept, Inc. BIOC Stock Holding History

Sterneck Capital Management’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Hold	0	–	-$7K	–	140
2016 Q2	–	Hold	0	–	–	–	128
2016 Q1	–	Hold	0	–	–	–	120
2015 Q4	–	Sell	-1	Closed	-$53.1K	–	122
2015 Q3	$32K	Hold	1	–	–	0.02%	121
2015 Q2	$50K	Hold	1	–	–	0.03%	136
2015 Q1	$53K	Buy	+1	New	+$67.2K	0.03%	132

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Sterneck Capital Management's BIOC Position: Q3 2016 in Review

Sterneck Capital Management held its Biocept, Inc. (BIOC) position steady in Q3 2016 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #140.

Sterneck Capital Management first reported a position in BIOC in Q1 2015 and has held it in 3 quarters since. The position peaked at $53K in Q1 2015. 6 funds tracked by Wall St. Rank hold BIOC as of Q3 2016.

Sterneck Capital Management held 0 shares of Biocept, Inc. worth $0 as of Q3 2016.
Sterneck Capital Management left its Biocept, Inc. share count unchanged in Q3 2016.
Biocept, Inc. made up ﹤0.01% of Sterneck Capital Management's portfolio in Q3 2016, its #140 holding.
Sterneck Capital Management first reported a position in Biocept, Inc. in Q1 2015 and has held it in 3 quarters since.
Sterneck Capital Management's Biocept, Inc. position peaked at $53K in Q1 2015.
6 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2016.

Based on Sterneck Capital Management's 13F filing for Q3 2016, filed 16 Nov 2016.